PMID: 6370987May 1, 1984

The use of depot neuroleptics: clinical experience in the United States

The Journal of Clinical Psychiatry
J M Kane

Abstract

The use of long-acting injectable preparations such as fluphenazine enanthate or decanoate can reduce patient noncompliance, but documenting this in a controlled research design is difficult. Several studies of relapse rates among patients receiving oral fluphenazine, depot fluphenazine, or placebo are reviewed. Factors that may explain the lack of significant differences among different drug treatments in preventing relapse are discussed. Indications are presented for the use of depot neuroleptics, and strategies for achieving minimum effective doses are reviewed. Adverse effects of depot medication are also discussed, so that the clinician may maximize the ratio of benefit to risk.

Related Concepts

Modecate
Moditen enanthate
Clinical Trials
Melancholia
Drug Administration Schedule
Lyogen
Patient Readmission
Placebos
Schizophreniform Disorders
Relapse

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here